Human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) remain leading causes of illness and death in the United States. The CDC has established guidelines for patients in all health care settings and pregnant women:1
LabCorp’s fourth generation HIV antigen/antibody assay is available with a CDC-recommended supplemental algorithm.
Fourth-generation HIV screening and associated supplemental testing is a valuable addition to the HIV screening tools especially for use in the high-risk populations where it will have its greatest impact. Detection of acute infections using the fourth-generation HIV screening assay provides an opportunity for early therapeutic intervention and the potential to reduce transmission rates.
LabCorp offers a wide range of HIV testing options.